Proteomics is no longer judged solely by the depth of discovery it enables, but by how effectively those discoveries can be carried into clinical research, drug development, and patient care. As ...

Colleen Kenney, partner and founder and head of the e-discovery and data analytics group at Sidley Austin and winner of Legalweek Leaders in Tech Law Lifetime Achievement Award, talks about the vital ...

Strategic outsourcing utilizes external expertise to accelerate the biopharma pipeline, integrating specialized workflows that drive efficiency from discovery through early clinical trials. *Full ...

The global AI drug discovery market is expected to reach a valuation of nearly $8bn by 2030. US-based generative AI drug creation company Absci Corporation has announced a collaboration with ...

Join us for an engaging webinar exploring how advances in target-based drug discovery are transforming the way therapeutics are designed and developed. This webinar will examine innovations in ...